nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/52/optimizedepts.washington.edu/hepstudy/presentations/uploads/52/optimize.p… ·...

div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: nfsbronfsuwfshw00d44hepstudypresentationsuploads52optimizedeptswashingtoneduhepstudypresentationsuploads52optimizep… · web study Twice Daily Telaprevir for src=https:reader034fdocumentsinreader034viewer20220502125f5e213bcdb1f24f1860da8ahtml5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: nfsbronfsuwfshw00d44hepstudypresentationsuploads52optimizedeptswashingtoneduhepstudypresentationsuploads52optimizep… · web study Twice Daily Telaprevir for src=https:reader034fdocumentsinreader034viewer20220502125f5e213bcdb1f24f1860da8ahtml5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: nfsbronfsuwfshw00d44hepstudypresentationsuploads52optimizedeptswashingtoneduhepstudypresentationsuploads52optimizep… · web study Twice Daily Telaprevir for src=https:reader034fdocumentsinreader034viewer20220502125f5e213bcdb1f24f1860da8ahtml5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: nfsbronfsuwfshw00d44hepstudypresentationsuploads52optimizedeptswashingtoneduhepstudypresentationsuploads52optimizep… · web study Twice Daily Telaprevir for src=https:reader034fdocumentsinreader034viewer20220502125f5e213bcdb1f24f1860da8ahtml5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: nfsbronfsuwfshw00d44hepstudypresentationsuploads52optimizedeptswashingtoneduhepstudypresentationsuploads52optimizep… · web study Twice Daily Telaprevir for...

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/52/optimizedepts.washington.edu/hepstudy/presentations/uploads/52/optimize.p… ·...

Documents

Transcript of nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/52/optimizedepts.washington.edu/hepstudy/presentations/uploads/52/optimize.p… ·...

Acute Hepatitis C Virus Infection: Epidemiology, Clinical ...depts.washington.edu/hepstudy/presentations/uploads/6/m1_l5acute_hep_c.pdfHepatitis web study HEPATITIS WEB STUDY H. Nina

Ombitasvir-Paritaprevir-Ritonavir (Techniviedepts.washington.edu/hepstudy/presentations/uploads/161/technivie... · 16/12/2015 · Ombitasvir-Paritaprevir-Ritonavir (Technivie)•

Treatment of HCV in Patients with HIV Coinfectiondepts.washington.edu/hepstudy/presentations/... · HCV/HIV co-infected versus HCV monoinfection (P

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration

Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir Viekira …depts.washington.edu/hepstudy/presentations/uploads/131/...Hepatitis web study Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir

State of the Art Therapy for HCV - University of Washingtondepts.washington.edu/hepstudy/presentations/...• Favorable clinical pharmacology profile - No food effect - No significant

CFOA UwFS Protocol Code of Practice v2

Addressing Psychiatric Issues Prior to HCV Treatmentdepts.washington.edu/hepstudy/presentations/uploads/35/m4_l3... · Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L,

nfs/bronfs/uwfs/hw00/d99/nwaetc/presentations/uploads/117 ...

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/81/...Source: Manns M, et al. Lancet. 2014;384:414-26. Simeprevir + PEG + RBV in Treatment-Naïve

Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase

Natural History of Hepatitis C Infectiondepts.washington.edu/hepstudy/presentations/... · Natural History of Hepatitis C Infection Recorded on May 15, 2013 . Slide 2 of 16 Disclosure

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous

Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis

nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve

ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein, DB et al Ann Intern Med 2012:156:263-70. web study HCV Testing of Persons Born

Sofosbuvir in Genotypes 2 or 3 VALENCE Trialdepts.washington.edu/hepstudy/presentations/uploads/93/valence.pdf · Sofosbuvir and Ribavirin for HCV GT 2 or 3 VALENCE: Results for GT

Phase 3 - University of Washingtondepts.washington.edu/hepstudy/presentations/... · Abbreviations: DCV = daclatasvir; SOF = sofosbuvir 97 78 100 89 50 92 0 20 40 60 80 100 Treatment

Treatment of Chronic HCV Genotype 5 or 6depts.washington.edu/hepstudy/presentations/uploads/126/m5_l5... · • Decompensated hepatic disease • Major uncontrolled depressive illness